Delivery Order SPE2DB24D9144-SPE2DB25FCNAN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml autoinjector on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The award...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,712.23 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector doses. The contract, effective through September 5, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois facility. This delivery order falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.44 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml auto-injectors, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was issued on September 8, 2025, with performance to take place in Park Ridge, Illinois. The award utilized no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,712.23 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector units. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on August 25, 2025, with an ultimate completion date of September 16, 2025, and was not designated under any federal...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 150 mg/ml Xolair auto-injectors valued at $1,712.22. This delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, utilizes firm fixed-price pricing and was awarded without set-aside designation. The award is issued under DMS Pharmaceutical Group's existing Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,712.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml autoinjectors, with a period of performance through October 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $30,820.14 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector units. The contract was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector units. This delivery order, issued on May 30, 2025, with a completion date of June 23, 2025, operates under a firm fixed-price structure with no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL autoinjectors. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete as a woman-owned small...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB25FCNANDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Xolair 150 mg/ml auto-injector units. This award represents a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA, valued at approximately $500 million and valid through November 2026. The contract carries no set-aside designation, and the place of performance is Park Ridge, Illinois, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that serves as a critical supplier within the federal pharmaceutical supply chain, primarily supporting Department of Defense healthcare facilities. The company maintains a robust portfolio of federal contracts covering an extensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, medical consumables, and specialty medications such as oncology treatments and auto-injectors. This delivery order for Xolair, a biologic medication used in immunology treatment, exemplifies DMS Pharmaceutical Group's continued role in fulfilling the medical supply requirements of military health facilities nationwide through the DLA's pharmaceutical distribution program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/16/25 |